We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Malin Corporation Plc | LSE:0Y71 | London | Ordinary Share | IE00BVGC3741 | MALIN CORPORATION ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 0 | 0 | - | N/A | 0 |
TIDM0Y71
RNS Number : 9834O
Malin Corporation PLC
13 October 2021
Malin Corporation plc
Malin provides update on Litigation by Founder Shareholders
Dublin-Ireland, 13 October 2021 : Malin Corporation plc (Euronext Growth Dublin:MLC) ("Malin", the "Company") announces, further to the announcement on 8 October 2021, that Irish High Court proceedings have been initiated by the holders of 2,803,801 A Ordinary Shares in the Company ("the Founders") against the Company.
The Founders claim an entitlement to the conversion of their A Ordinary Shares into Ordinary Shares and have reserved their right to apply to Court in the course of the legal proceedings for an Order restraining the Company from implementing any capital returns to ordinary shareholders of Malin pending the conversion. As announced on 8 October 2021, the Company rejected the conversion notices previously submitted to the Company by the Founders, on the basis that no change of control has occurred and the conversion rights carried by A Ordinary Shares are not currently exercisable.
The Board will take all necessary steps to vigorously defend the Company and shareholders against the Founders' proceedings.
The Company remains intent on initiating a significant return of capital to its shareholders by means of a tender offer before the end of 2021.
Further announcements will be made in due course as and when appropriate.
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.
Our purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com
For further information contact:
Malin
Jessica Bergin, Investor Relations & External Reporting
Tel: +353 (0)1 901 5700
investorrelations@malinplc.com
Davy Corporate Finance (Euronext Growth Adviser & Joint Broker)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Liberum (Joint Broker)
Bidhi Bhoma / Euan Brown
Tel: +44 (0) 20 3100 2000
Powerscourt (Media enquiries)
Rory Godson / Eavan Gannon
Tel: +44 7909 926020 / +353 87 236 5973
malin@powerscourt-group.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDEAAEDFSXFFFA
(END) Dow Jones Newswires
October 13, 2021 09:10 ET (13:10 GMT)
1 Year Malin Chart |
1 Month Malin Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions